Glaukos Corp Stock Probability of Future Stock Price Finishing Under 104.45
GKOS Stock | USD 151.22 2.86 1.93% |
Glaukos |
Glaukos Corp Target Price Odds to finish below 104.45
The tendency of Glaukos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to drop to $ 104.45 or more in 90 days |
151.22 | 90 days | 104.45 | near 1 |
Based on a normal probability distribution, the odds of Glaukos Corp to drop to $ 104.45 or more in 90 days from now is near 1 (This Glaukos Corp probability density function shows the probability of Glaukos Stock to fall within a particular range of prices over 90 days) . Probability of Glaukos Corp price to stay between $ 104.45 and its current price of $151.22 at the end of the 90-day period is about 99.0 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.54 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Glaukos Corp will likely underperform. Additionally Glaukos Corp has an alpha of 0.2178, implying that it can generate a 0.22 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Glaukos Corp Price Density |
Price |
Predictive Modules for Glaukos Corp
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Glaukos Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Glaukos Corp Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Glaukos Corp is not an exception. The market had few large corrections towards the Glaukos Corp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Glaukos Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Glaukos Corp within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 1.54 | |
σ | Overall volatility | 6.89 | |
Ir | Information ratio | 0.1 |
Glaukos Corp Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Glaukos Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Glaukos Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.The company reported the previous year's revenue of 314.71 M. Net Loss for the year was (134.66 M) with profit before overhead, payroll, taxes, and interest of 213.88 M. | |
Glaukos Corp currently holds about 391.19 M in cash with (57.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22. | |
Glaukos Corp has a frail financial position based on the latest SEC disclosures | |
Over 97.0% of the company shares are owned by institutional investors | |
Latest headline from gurufocus.com: Glaukos Submits New Drug Application to U.S. FDA for Epioxa |
Glaukos Corp Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Glaukos Stock often depends not only on the future outlook of the current and potential Glaukos Corp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Glaukos Corp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 48.4 M | |
Cash And Short Term Investments | 295.4 M |
Glaukos Corp Technical Analysis
Glaukos Corp's future price can be derived by breaking down and analyzing its technical indicators over time. Glaukos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Glaukos Corp. In general, you should focus on analyzing Glaukos Stock price patterns and their correlations with different microeconomic environments and drivers.
Glaukos Corp Predictive Forecast Models
Glaukos Corp's time-series forecasting models is one of many Glaukos Corp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Glaukos Corp's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Glaukos Corp
Checking the ongoing alerts about Glaukos Corp for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Glaukos Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the previous year's revenue of 314.71 M. Net Loss for the year was (134.66 M) with profit before overhead, payroll, taxes, and interest of 213.88 M. | |
Glaukos Corp currently holds about 391.19 M in cash with (57.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.22. | |
Glaukos Corp has a frail financial position based on the latest SEC disclosures | |
Over 97.0% of the company shares are owned by institutional investors | |
Latest headline from gurufocus.com: Glaukos Submits New Drug Application to U.S. FDA for Epioxa |
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.